Skip to content
HowShorted

How shorted is UroGen Pharma Ltd.? URGN

#430most shorted US stockof 3,805 ranked stocks, more shorted than 88%

12.78%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
0.00
5 reports (~10 weeks)
+0.02
days to cover
9.16
Aggregate net short position time series for UroGen Pharma Ltd.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for UroGen Pharma Ltd. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
5 Aug 20269.39% 31 Jul 202610.48% 14 Aug 2026+1.09
6 May 202615.46% 30 Apr 202613.88% 15 May 2026−1.58
2 Mar 202617.13% 27 Feb 202618.44% 13 Mar 2026+1.31
6 Nov 202524.11% 31 Oct 202519.18% 14 Nov 2025−4.93
7 Aug 202515.49% 31 Jul 202514.85% 15 Aug 2025−0.64
12 May 202510.88% 30 Apr 202512.12% 15 May 2025+1.24
10 Mar 202514.50% 28 Feb 202514.57% 14 Mar 2025+0.07
6 Nov 202415.67% 31 Oct 202415.27% 15 Nov 2024−0.40

Fails to deliver

The SEC's fails-to-deliver figure for URGN: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
133
17 Aug 2026
Highest in window
740,719
20 Nov 2025
Days with a balance
67
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for UroGen Pharma Ltd. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 741K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202612.78%0.00
31 Aug 202612.78%+2.30
14 Aug 202610.48%+1.09
31 Jul 20269.39%−2.29
15 Jul 202611.68%−1.08
30 Jun 202612.76%−0.70
15 Jun 202613.46%−0.75
29 May 202614.21%+0.33
15 May 202613.88%−1.58
30 Apr 202615.46%−1.26
15 Apr 202616.72%−1.12
31 Mar 202617.84%−0.60
13 Mar 202618.44%+1.31
27 Feb 202617.13%−2.81
13 Feb 202619.94%−2.06
30 Jan 202622.00%−0.58
15 Jan 202622.58%+2.20
31 Dec 202520.38%+3.85
15 Dec 202516.53%−0.45
28 Nov 202516.98%−2.20
14 Nov 202519.18%−4.93
31 Oct 202524.11%+0.01
15 Oct 202524.10%+5.26
30 Sep 202518.84%+1.67
15 Sep 202517.17%+2.00
29 Aug 202515.17%+0.32
15 Aug 202514.85%−0.64
31 Jul 202515.49%−0.33
15 Jul 202515.82%+3.99
30 Jun 202511.83%−1.45
13 Jun 202513.28%+4.79
30 May 20258.49%−3.63
15 May 202512.12%+1.24
30 Apr 202510.88%−1.11
15 Apr 202511.99%−1.40
31 Mar 202513.39%−1.18
14 Mar 202514.57%+0.07
28 Feb 202514.50%−0.17
14 Feb 202514.67%+0.08
31 Jan 202514.59%+0.39
15 Jan 202514.20%+0.39
31 Dec 202413.81%+0.03
13 Dec 202413.78%+0.10
29 Nov 202413.68%−1.59
15 Nov 202415.27%−0.40
31 Oct 202415.67%+0.26
15 Oct 202415.41%−1.38
30 Sep 202416.79%+1.67
13 Sep 202415.12%−0.18
30 Aug 202415.30%−0.10
15 Aug 202415.40%−1.49
31 Jul 202416.89%+0.64
15 Jul 202416.25%−1.29
28 Jun 202417.54%+1.98
14 Jun 202415.56%+1.01
31 May 202414.55%+2.18
15 May 202412.37%+0.10
30 Apr 202412.27%−1.33
15 Apr 202413.60%+0.04
28 Mar 202413.56%−0.21
15 Mar 202413.77%+1.02
29 Feb 202412.75%−0.25
15 Feb 202413.00%+2.45
31 Jan 202410.55%−0.44
12 Jan 202410.99%−0.50
29 Dec 202311.49%+1.54
15 Dec 20239.95%+0.50
30 Nov 20239.45%+0.29
15 Nov 20239.16%+1.60
31 Oct 20237.56%+2.13
13 Oct 20235.43%+0.70
29 Sep 20234.73%+0.46
15 Sep 20234.27%−0.38
31 Aug 20234.65%−0.84
15 Aug 20235.49%−1.21
31 Jul 20236.70%+2.38
14 Jul 20234.32%+0.44
30 Jun 20233.88%+1.08
15 Jun 20232.80%−0.84
31 May 20233.64%−0.39
15 May 20234.03%+0.91
28 Apr 20233.12%−0.05
14 Apr 20233.17%+0.44
31 Mar 20232.73%+0.02
15 Mar 20232.71%+0.14
28 Feb 20232.57%+0.07
15 Feb 20232.50%+0.03
31 Jan 20232.47%0.00
13 Jan 20232.47%−0.44
30 Dec 20222.91%0.00
15 Dec 20222.91%0.00
30 Nov 20222.91%−0.03
15 Nov 20222.94%−0.36
31 Oct 20223.30%−1.56
14 Oct 20224.86%−1.23
30 Sep 20226.09%−0.20
15 Sep 20226.29%+0.08
31 Aug 20226.21%−0.22
15 Aug 20226.43%−0.07
29 Jul 20226.50%−0.21
15 Jul 20226.71%−0.79
30 Jun 20227.50%−2.10
15 Jun 20229.60%−1.17
31 May 202210.77%+0.38
13 May 202210.39%+0.22
29 Apr 202210.17%+0.95
14 Apr 20229.22%+0.37
31 Mar 20228.85%−0.96
15 Mar 20229.81%−0.05
28 Feb 20229.86%+0.96
15 Feb 20228.90%+0.01
31 Jan 20228.89%+0.66
14 Jan 20228.23%+0.17
31 Dec 20218.06%−0.38
15 Dec 20218.44%+0.31
30 Nov 20218.13%+0.82
15 Nov 20217.31%−0.51
29 Oct 20217.82%−0.03
15 Oct 20217.85%−0.44
30 Sep 20218.29%−0.90
15 Sep 20219.19%−0.70
31 Aug 20219.89%−0.05
13 Aug 20219.94%+0.73
30 Jul 20219.21%−0.19
15 Jul 20219.40%−0.15
30 Jun 20219.55%−0.65
15 Jun 202110.20%−0.81
28 May 202111.01%+0.54
14 May 202110.47%−0.03
30 Apr 202110.50%−0.14
15 Apr 202110.64%+0.17
31 Mar 202110.47%−0.61
15 Mar 202111.08%−1.43
26 Feb 202112.51%+0.19
12 Feb 202112.32%+0.47
29 Jan 202111.85%−0.11
15 Jan 202111.96%−0.22
31 Dec 202012.18%+1.00
15 Dec 202011.18%−1.20
30 Nov 202012.38%+0.34
13 Nov 202012.04%−1.64
30 Oct 202013.68%−0.51
15 Oct 202014.19%−0.27
30 Sep 202014.46%−0.09
15 Sep 202014.55%+0.43
31 Aug 202014.12%−0.11
14 Aug 202014.23%+0.30
31 Jul 202013.93%+0.31
15 Jul 202013.62%+0.71
30 Jun 202012.91%+0.66
15 Jun 202012.25%−0.37
29 May 202012.62%+0.23
15 May 202012.39%−0.18
30 Apr 202012.57%+0.38
15 Apr 202012.19%+1.15
31 Mar 202011.04%+0.90
13 Mar 202010.14%−1.35
28 Feb 202011.49%+0.16
14 Feb 202011.33%−0.11
31 Jan 202011.44%+1.36
15 Jan 202010.08%+1.50
31 Dec 20198.58%−2.76
13 Dec 201911.34%+0.12
29 Nov 201911.22%−0.09
15 Nov 201911.31%+0.46
31 Oct 201910.85%−0.39
15 Oct 201911.24%–

Newest first. Scroll inside the table for earlier dates, back to 15 Oct 2019.

Frequently asked questions

How shorted is UroGen Pharma Ltd. right now?
12.78% of UroGen Pharma Ltd.'s (URGN) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 430th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this URGN's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is URGN's days to cover?
9.16 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.